Screener
Oruka Therapeutics, Inc. ORKA Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Oruka Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055769
FAQ
- What is Oruka Therapeutics, Inc.'s current ratio?
- Oruka Therapeutics, Inc. (ORKA) reported current ratio of 23.8× in Q1 2026.
- How has Oruka Therapeutics, Inc.'s current ratio changed year-over-year?
- Oruka Therapeutics, Inc.'s current ratio decreased by 20.9% year-over-year, from 30× to 23.8×.
- What is the long-term trend for Oruka Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s current ratio has grown at a 9.4% compound annual growth rate (CAGR), from 14.3× to 22.4×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Oruka Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude